Natural Alzheimer's weapon suggests better treatment

June 20, 2011 in Medical research
Natural Alzheimer's weapon suggests better treatment

Enlarge

Dr. Anil G. Cashikar (left) and Graduate Student Juhi Ojha have identified a natural mechanism for managing high levels of toxic amyloid beta peptide that occurs in Alzheimer's disease. Credit: Phil Jones/GHSU photograhper

Scientists have shown a molecular chaperone is working like a waste management company to collect and detoxify high levels of toxic amyloid beta peptide found in Alzheimer's disease.

It was known that the molecular chaperone, HspB1, was present in the hallmark plaque of Alzheimer's patients but its role remained a mystery.

"What we have found is HspB1 is a that tries to get rid of the toxic or aggregates of amyloid beta that occur in Alzheimer's," said Dr. Anil G. Cashikar, at Georgia Health Sciences University's Center for Molecular Chaperones and Radiobiology. He is corresponding author of the study published in .

Amyloid beta peptide, or Abeta, is believed to start the cascade of events that leads to and death in Alzheimer's: as levels increase, the peptide starts clumping in the brain. In fact, high levels in the spinal fluid are a for the disease. Molecular chaperones are known for their propensity to respond to disease-producing misfolded proteins, which is how the body views excessive Abeta.

While resulting plaques occupy prime real estate in the brain, it's still better than toxic Abeta killing neurons, Cashikar said. "We think maybe the system gets overwhelmed."

Acknowledging much work remains, the scientist is excited about identifying the protective mechanism and exploring its treatment potential.

Earlier this year, a paper Cashikar published in PLoS One showed deleting genes with a similar function from a of Alzheimer's worsened disease symptoms. The new study also showed neurons from HspB1-deficient mice were more sensitive to the toxic ravages of Abeta.

"HspB1 is present because its function is to protect cells. The implication is if we can elevate the levels of this molecular chaperone, we may be able to handle the situation a little better," Cashikar said.

He wants to exploit this natural system by developing a smaller version of the that could be put into the bloodstream to leach excess Abeta from the brain. The brain has a natural protective mechanism that likely would prevent its direct application. However, the natural affinity of amyloid beta and HspB1 indicates a more distant approach could be effective. "We want to come up with smaller versions of HspB1 that can be put into the bloodstream so you can sop up the material from the brain into the blood where it can be cleared more efficiently." He also wants to explore a way to increase brain cells' natural production of protective HspB1.

Neurons actually also make the Abeta believed to attack them in Alzheimer's. The peptide's normal function in the is not clear, but early evidence suggests it could be involved in synaptic pruning, which is essential for memory formation. Synapses connect neurons and some existing connections must be cut for new connections and memories to be made. Why neurons start making too much Abeta and how its overproduction can be controlled are million-dollar questions, Cashikar said.

A related ongoing debate is whether the amyloid plaques and neurofibrillarly tangles, insoluble globs of protein also found in Alzheimer's, are a cause or result of the disease. Cashikar's work as well as new studies on the neurofibrillarly tangles, suggest both are protective mechanisms. Also, there is evidence of both in the brains of some healthy, elderly individuals.

GHSU Graduate Student Juhi Ojha is first author on the paper.

Provided by Georgia Health Sciences University

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

The cells' petrol pump is finally identified

The oxygen and food we consume are converted into energy by tiny organelles present in each cell, the mitochondria. These 'power plants' must be continuously supplied with fuel, to maintain all vital functions. A team led ...

Medical research created 7 hours ago | popularity 5 / 5 (1) | comments 0

Researchers identify protein necessary for behavioral flexibility

Researchers have identified a protein necessary to maintain behavioral flexibility, which allows us to modify our behaviors to adjust to circumstances that are similar, but not identical, to previous experiences. Their findings, ...

Medical research created 9 hours ago | popularity 5 / 5 (1) | comments 1 | with audio podcast

From stem cell to brain cell - new technique mimics the brain

A new technique that converts stem cells into brain cells has been developed by researchers at Lund University. The method is simpler, quicker and safer than previous research has shown and opens the doors to a shorter route ...

Medical research created 11 hours ago | popularity 5 / 5 (1) | comments 0

A revealing hand

What did you have for lunch yesterday? How many times a month do you eat nuts? How about your kids -- how many servings of vegetables did they consume today?

Medical research created 15 hours ago | popularity 5 / 5 (2) | comments 0

Stem-cell-growing surface enables bone repair

(Medical Xpress) -- University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. ...

Medical research created May 23, 2012 | popularity 5 / 5 (9) | comments 1 | with audio podcast


Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...